Health Service Policy
A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment.
A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England.
Linking cancer drug prices to treatment success could speed up approvals. But what do patients consider success?
With NHS budgets stretched, it’s critical that cancer drugs offer value for money. We’ve teamed up with the Greater Manchester Health and Social Care Partnership to...
The NHS long-term plan contains ambitious commitments to diagnose more cancers earlier and boost prevention, but it lacks detail on tackling staff shortages.
Cancer Research UK welcomes the long term NHS plan, which reiterates the Prime Minister’s ambition to improve cancer survival for patients.
The Prime Minister committed to diagnosing cancers earlier – so how many staff does the NHS need to get there?
Our new report estimates the number of cancer staff the NHS will need in the future so that people with cancer receive the best possible care.
With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments.
Theresa May’s commitment to diagnosing cancers earlier is great news. She’ll need more NHS staff to get there
For the Prime Minister to reach her ambitions of 3 in 4 cancer patients diagnosed early in the next 10 years, NHS staff shortages must be addressed.